Summary & Overview
HCPCS Level II A7030: Full Face Mask for Positive Airway Pressure Devices
Headline: HCPCS Level II code A7030: Full Face Mask for Positive Airway Pressure Devices
Lead: HCPCS Level II code A7030 identifies a full face mask supplied for use with positive airway pressure (PAP) devices, an important DME component in the management of sleep-disordered breathing and chronic respiratory insufficiency. Nationally, coverage and billing practices for interface supplies like full face masks affect access to effective noninvasive ventilation and ongoing adherence to home PAP therapy.
What the code represents and why it matters: A7030 denotes a single full face mask used with PAP devices. These masks are central to therapy delivery for patients who require a mouth-and-nose interface rather than nasal-only interfaces. As a DME supply, correct coding ensures appropriate supply provision, continuity of care, and accurate claims processing across payers.
Key payers covered: The analysis addresses major national commercial payers including Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare.
Overview of reader takeaways: Readers will find a concise explanation of the clinical context for full face PAP interfaces, payer coverage considerations, commonly used billing modifiers, related supply codes, and typical diagnosis pairings used to support medical necessity. The publication also outlines documentation and coding elements that influence claims adjudication and common areas where additional medical policy criteria may apply.
Scope note: Service details and payer-specific policy language vary; Data not available in the input for payer-specific rates or regional policy differences.
Billing Code Overview
HCPCS Level II code A7030 describes a full face mask used with a positive airway pressure device, each. This item is classified as a Durable Medical Equipment (DME) supply and is typically billed by a DME supplier for use in the home setting. The code covers the individual full face mask component intended for use with PAP therapy devices to support noninvasive ventilation and airway pressure delivery.
Clinical & Coding Specifications
Clinical Context
A patient diagnosed with obstructive sleep apnea (G47.33) presents after evaluation by a pulmonary disease physician or respiratory therapist for initiation of positive airway pressure therapy. The durable medical equipment supplier assesses the patient’s mask fit and documents clinical necessity. The supplier bills HCPCS Level II code A7030 for a full face mask used with a positive airway pressure device when the patient requires a mask covering both nose and mouth due to mouth breathing, nasal obstruction, or high pressure settings. Typical workflow: clinician documents diagnosis and medical necessity, writes DME order specifying full face mask, supplier obtains prior authorization if required, supplies mask to patient at home, and bills under the DME supply site of service using appropriate modifiers and supporting documentation.
Coding Specifications
-
Modifiers (use cases):
-
NU- New Equipment: used when the full face maskA7030is provided as new equipment to the beneficiary for the first rental or purchase episode. -
RR- Rental: used whenA7030is billed as a rental item under a rental agreement rather than as a purchase. -
KX- Requirements specified in the medical policy have been met: used when documentation supports that payer-specific medical necessity criteria are satisfied (e.g., clinical notes, prior authorization approval) for billingA7030. -
Provider taxonomies and specialties:
-
207RP1001X- Pulmonary Disease Physician: specialty that diagnoses conditions like obstructive sleep apnea or chronic respiratory failure and writes DME orders. -
227900000X- Respiratory Therapist, Certified: allied health professional who assesses mask fit, provides patient education, and documents device usage. -
2278C0205X- Critical Care Respiratory Therapist: advanced respiratory therapist involved when higher-acuity respiratory support or complex mask fitting is needed.
Related Diagnoses
G47.33- Obstructive sleep apnea (adult) (pediatric)
Clinical relevance: Obstructive sleep apnea commonly requires positive airway pressure therapy; a full face mask A7030 is used when nasal interfaces are ineffective or the patient is a mouth breather.
J96.10- Chronic respiratory failure with hypoxia
Clinical relevance: Patients with chronic hypoxic respiratory failure may use positive airway pressure support at home; a full face mask may be indicated based on interface needs and ventilation parameters.
J96.11- Chronic respiratory failure with hypercapnia
Clinical relevance: Hypercapnic respiratory failure can require higher pressures or volume support where a full face mask A7030 provides an appropriate seal for effective therapy.
J44.9- Chronic obstructive pulmonary disease, unspecified
Clinical relevance: COPD patients with sleep-disordered breathing or chronic respiratory insufficiency may be candidates for positive airway pressure therapy; mask selection (full face vs nasal) depends on clinical assessment.
R06.02- Shortness of breath
Clinical relevance: Shortness of breath as a symptom may lead to evaluation for respiratory insufficiency or sleep-disordered breathing; when positive airway pressure is prescribed, A7030 may be used if a full face interface is required.
Related Codes
A7034- Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap
Explanation: A7034 is an alternative interface used with positive airway pressure devices when a nasal-only interface is appropriate. In clinical workflow, A7034 may be used instead of HCPCS Level II code A7030 when the patient does not require a full face mask. Suppliers may bill A7030 and A7034 separately when different interfaces are provided at different times, but they are typically alternatives for the same therapy delivery method.
National Reimbursement Benchmarks
Commercial mean rates for HCPCS Level II code A7030 are generally above the Medicare/BUCA average in some payers and below in others; Medicare/BUCA (average commercial benchmark) mean is $98.84, while Blue Cross Blue Shield posts the highest commercial mean at $112.60 and Cigna Health posts the lowest at $85.36. The national mean for Aetna is $89.62 and UnitedHealthcare is $101.68, situating payers across and around the Medicare/BUCA average.
Rate dispersion varies notably by payer. Blue Cross Blue Shield shows the widest spread between the 75th and 25th percentiles (134.00 - 91.00 = $43.00), indicating greater variability, while Cigna Health is the tightest with no dispersion (71.00 - 71.00 = $0.00). Aetna and UnitedHealthcare show moderate dispersion ($24.50 and $46.50 respectively when comparing P75 and P25), and BUCA/Medicare mirror each other with a $36.33 spread. The table and chart below present the full breakdown.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.